Cathie Wood’s ARK Invest Buys Over 170,000 Shares of Pfizer

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 170,000 shares of Pfizer Inc. (NYSE: PFE) on Thursday, as the price of this fund was down over 1% in the day’s session. It is still up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 173,579 shares of Pfizer. At Thursday’s closing price, this would have valued this purchase at roughly $8.2 million. This is only a small fraction of the total holdings. The fund is up 36% over the past 52 weeks.

Check out all the ARK Invest buys for Thursday:

FundTickerNameShares
ARKFPDDPINDUODUO59,300
ARKFCOINCOINBASE GLOBAL7,054
ARKGRPTXREPARE THERAPEUTICS2,468
ARKGQSIQUANTUM-SI34,201
ARKGPSNLPERSONALIS40,468
ARKGPFEPFIZER173,579
ARKGMASS908 DEVICES25,000
ARKGDYNSDYNAMICS SPECIAL PURPOSE1,696
ARKGADPTADAPTIVE BIOTECHNOLOGIES62,252
ARKGBEAMBEAM THERAPEUTICS17,033
ARKGCMIIUCM LIFE SCIENCES II25,000
ARKKVCYTVERACYTE26,653
ARKKNVTAINVITAE319,045
ARKKSGFYSIGNIFY HEALTH178,955
ARKKFATEFATE THERAPEUTICS60,075
ARKQKTOSKRATOS DEFENSE & SECURITY SOLUTIONS201,508
ARKQKMTUYKOMATSU21,700
ARKQAVAVAEROVIRONMENT8,767
ARKQACICATLAS CREST INVESTMENT460,000
ARKWSPLKSPLUNK116,466
ARKWLPSNLIVEPERSON23,856
ARKWGENIGENIUS SPORTS135,457
ARKXPRNT3D PRINTING ETF12,670

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Source: Read Full Article